The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label ...

Tourism Northern Ireland has described the recent Amgen Irish Open in Co Down as “incredibly successful”. More than 71,000 ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.

In addition to Dr. Bachleda, members of the Eyconis Board of Directors include Dr. Cunningham, who serves as Executive Chair, Jan Mikkelsen, President & CEO of Ascendis Pharma A/S, Daniel Estes, Ph.D.

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Amgen Inc. closed $13.93 short of its 52-week high ($346.85), which the company reached on July 25th.

The Congressional Black Caucus Foundation's Annual Legislative Conference panel on the Road to Health Equity discussed the ...

On June 28, 2024, the United States Patent and Trademark Office (“USPTO”) requested the public’s views on the current state ...

Researchers reported at the ESMO Congress that 78 percent of patients responded to front-line treatment with Lumakras, ...